ACS report: 2024 projected new cancer cases top 2 million

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Despite the continuing overall decline in cancer death rates—driven by reduction in tobacco use, improvements in early detection, and advances in treatment—the projected number of new diagnoses now tops 2 million for the first time, according to the American Cancer Society’s 2024 Cancer Statistics report. 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Jacquelyn Cobb
Associate Editor
Table of Contents

YOU MAY BE INTERESTED IN

The University of Texas MD Anderson Cancer Center and AmMax Bio, Inc. announced a worldwide exclusive license agreement and clinical trial agreement to develop and advance AmMax’s AMB-066 monoclonal antibody therapy as a first-in-class treatment option for patients with colorectal cancer and minimal residual disease as well as those with MRD in other solid tumors.
Jacquelyn Cobb
Associate Editor

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login